Anti-Vaccine Info in Pregnancy May Delay Infant Immunization

Share this content:
Anti-Vaccine Info in Pregnancy May Delay Infant Immunization
Anti-Vaccine Info in Pregnancy May Delay Infant Immunization

MONDAY, Aug. 21, 2017 (HealthDay News) -- Pregnancy is an important time for educating about infant immunization, according to a study published online Aug. 18 in Pediatrics.

The research included information gathered from 2009 to 2010 from 6,182 pregnant women in New Zealand. More than half of the women (56 percent) received no information at all about childhood vaccines while they were pregnant. About a third (30 percent) received only positive information about vaccines, while 4 percent received solely negative information. Ten percent received both negative and positive input.

The researchers found that 71 percent of infants whose mothers received no vaccine information in pregnancy were given their vaccines on time. Seventy-three percent of infants whose mothers only got positive information had their babies vaccinated on time. But only 57 percent of babies whose mothers heard only negative information got their vaccines on schedule. If women were given both good and bad information, 61 percent of their babies were immunized on time.

"Most said they received only encouraging information from health care providers, while the main sources of discouraging information were family and friends and media," study coauthor Cameron Grant, M.D., Ph.D., head of the department of pediatrics, child and youth health at the University of Auckland in New Zealand, told HealthDay. "But it was concerning that one in six women who recalled receiving discouraging information, identified health care providers as a source of that information. Health professionals caring for pregnant women have a very important role to play in determining the immunization intentions of these future parents, and in promoting infant immunization."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »